Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
Components of the human-specific, p53-mediated “kill switch” tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation
Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways
The role of exosomal long non-coding RNAs in cancer drug resistance
The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia
Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts
RET in breast cancer: pathogenic implications and mechanisms of drug resistance
Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
Network rewiring, adaptive resistance and combating strategies in breast cancer
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
Cancer stem cells in neuroblastoma therapy resistance
Liquid biopsy in metastatic breast cancer
Liquid biopsies in myeloid malignancies
Kinase inhibitors: look beyond the label on the bottle
In search of effective therapies to overcome resistance to Temozolomide in brain tumours
Exosomal lncRNAs: the newest promising liquid biopsy
Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer